LINC01187: A Potential Drug Target and Biomarker (G100507267)

Target Name: LINC01187

NCBI ID: G100507267

Other Name(s): KIDR | CTB-27N1.1 | Long intergenic non-protein coding RNA 1187 | long intergenic non-protein coding RNA 1187

LINC01187: A Potential Drug Target and Biomarker

LINC01187 is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. The gene is located on chromosome 6p and encodes for a protein known as LINC01187, which is a scaffold protein that is involved in the regulation of cellular processes such as cell adhesion, migration, and invasion.

LINC01187 has been shown to be involved in the development and progression of various diseases, including cancer. For example, studies have shown that high levels of LINC01187 are associated with poor prognosis in patients with pancreatic cancer, and that downregulation of LINC01187 has been shown to promote the growth and survival of pancreatic cancer cells.

In addition to its potential as a drug target, LINC01187 has also been identified as a potential biomarker for several diseases. For example, studies have shown that LINC01187 is expressed in the brains of individuals with Alzheimer's disease, and that downregulation of LINC01187 has been shown to contribute to the development of neurodegenerative symptoms in these individuals.

Another study has also shown that LINC01187 is expressed in the blood vessels of individuals with hypertension, and that downregulation of LINC01187 has been shown to contribute to the development of cardiovascular disease in these individuals.

In conclusion, LINC01187 is a gene that has the potential to be a drug target and biomarker for various diseases. Further research is needed to fully understand its role in these conditions and to develop effective treatments.

Protein Name: Long Intergenic Non-protein Coding RNA 1187

More Common Targets